Arbutus Biopharma Corporation (ABUS)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 2.6900 |
| 開市 | 2.6400 |
| 買盤 | 2.6500 x 100 |
| 賣出價 | 2.7200 x 100 |
| 今日波幅 | 2.6300 - 2.7300 |
| 52 週波幅 | 1.6900 - 3.2900 |
| 成交量 | |
| 平均成交量 | 1,401,554 |
| 市值 | 482.869M |
| Beta 值 (5 年，每月) | 2.09 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.4400 |
| 業績公佈日 | 2024年8月01日 - 2024年8月05日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 4.40 |
ZacksArbutus Biopharma (ABUS) Reports Q1 Loss, Misses Revenue Estimates
Arbutus (ABUS) delivered earnings and revenue surprises of 0% and 28.91%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksAre Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?
Here is how Arbutus Biopharma (ABUS) and Entera Bio Ltd. (ENTX) have performed compared to their sector so far this year.
Insider MonkeyArbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript February 29, 2024 Arbutus Biopharma Corporation reports earnings inline with expectations. Reported EPS is $-0.12 EPS, expectations were $-0.12. ABUS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and […]
